跳至主要内容
临床试验/NL-OMON44829
NL-OMON44829已完成不适用

RandomizEd Controlled Trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer. - RECTAL BOOST study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 142 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Participant in the PLCRC project (METC 12-510).
  • * Informed consent obtained for being offered experimental interventions within the PLCRC project.
  • * Informed consent obtained for questionnaires on patient reported outcomes within the PLCRC project.
  • * WHO: 0-2.
  • * T3+ (circumferential resection margin (CRM) positive) T4N0-1 or N2 M0-1 (if resectable liver and/or lung metastases).
  • * Referred for chemoradiation.
  • * No contra-indication for MRI.
  • * Tumor distance from ano-rectal transition *10cm.

排除标准

  • * T3 (limited volume / CRM negative).
  • * Inflammatory bowel disease.
  • * Prior pelvic radiotherapy.
  • * At least one contra-indication for capecitabine administration (based on DPD-deficiency, blood count, liver malfunction, renal failure (Creatinine clearance <30ml/min, medical history such as recent cardiac events).
  • * Recent pregnancy *1 year ago.
  • * Inadequate understanding of the Dutch language in speech and/or writing.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验